ANAHEIM GARDENS, L.P. v. US [OPINION]
Sourcing
Patent Insights
March 25, 2020 Discovering and developing treatments in order to alleviate suffering, bend the mortality curve and improve quality of life is a long journey. It comprises many innovative stages: in short, it starts with the understanding of the process behind a disease, followed by the identification of a molecule or compound and then by …
“The Sanofi decision behooves drug sponsor, generic manufacturers, and drug purchasers alike to examine the Orange Book listings for potentially improperly listed patents.” The U.S. Court of Appeals for the First Circuit has made brand companies think twice about creating patent thickets in the Orange Book by resuscitating an antitrust suit against Sanofi by direct …
“When we do come up with a vaccine (or more than one) the government is going to be the buyer…. And, if necessary, the government has the power to seize business assets (including inventions) to allow it to deal with a national emergency first and worry about fair compensation later. So, you’ll spend your time …
Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them Read More »
Hey Reddit! I’ve been working on this device to help hearing impaired individuals enjoy music and it would really help if you guys completed this survey I made to help me design my solution. It should only take 5-10 min and will come a long way in helping me develop a better prototype, so I …
Yesterday, the U.S. Court of Appeals for the Federal Circuit denied rehearing en banc in Arthrex v. Smith & Nephew. Five of the 12 Federal Circuit judges wrote separately to explain their reasons for denying, or dissenting from denial on, rehearing. IPWatchdog Founder and CEO Gene Quinn said the order reveals a chaotic and disorganized …
The IP Bar Weighs in on CAFC Denial of Arthrex Rehearing Read More »
submitted by /u/flockofwolves [link] [comments] Sourcing Info
“Even if the Alternative for Germany party, which is said to be critical of the UPC, and the communist party, which voted against subsequent UPC related legislation, were to vote against the approval act, the government should have no difficulty in securing a 2/3 majority.” On Friday, March 20, the German Constitutional Court (“Bundesverfassungsgericht”, “BverfG”) …